Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation

Purpose: To determine the incidence and risk factors of bleeding events as well as assess the performance of the PRECISE-DAPT score in elderly patients (≥75 years) who underwent percutaneous coronary intervention (PCI) and one-year dual antiplatelet therapy (DAPT).Methods: A total of 940 patients (≥...

Full description

Bibliographic Details
Main Authors: Yanxia Qian, Bing Xu, Xiaodong Qian, Lu Cao, Yujia Cheng, Xinjian Liu, Song Bai, Zhijun Han, Junhong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.661619/full
id doaj-1b3ff168d62246b18c642b34588bcb32
record_format Article
spelling doaj-1b3ff168d62246b18c642b34588bcb322021-07-30T08:32:40ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-07-011210.3389/fphar.2021.661619661619Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective ObservationYanxia Qian0Bing Xu1Xiaodong Qian2Lu Cao3Yujia Cheng4Xinjian Liu5Xinjian Liu6Song Bai7Zhijun Han8Junhong Wang9Junhong Wang10Department of Cardiology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, Northern Jiangsu Province Hospital and Clinical Medical College, Yangzhou University, Yangzhou, ChinaDepartment of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaDepartment of Cardiology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, ChinaDepartment of Pathogenic Microorganism, Nanjing Medical University, Nanjing, ChinaKey Laboratory of Antibody Technique of National Health Commission of China, Department of Pathogen Biology, Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, Xuyi People’s Hospital, Huai’an, ChinaDepartment of Laboratory Medicine, The Affiliated Wuxi No.2 People’s Hospital of Nanjing Medical University, Wuxi, ChinaDepartment of Cardiology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, ChinaDepartment of Cardiology, Xuyi People’s Hospital, Huai’an, ChinaPurpose: To determine the incidence and risk factors of bleeding events as well as assess the performance of the PRECISE-DAPT score in elderly patients (≥75 years) who underwent percutaneous coronary intervention (PCI) and one-year dual antiplatelet therapy (DAPT).Methods: A total of 940 patients (≥75 years) who received PCI and one-year DAPT were retrospectively enrolled into the study. The multivariable logistic regression analysis was conducted to identify risk factors of antiplatelet-related bleeding complications. The receiver operating characteristic (ROC) curve analysis and the Delong test were performed to obtain the optimized PRECISE-DAPT score.Results: It was observed that 89 (9.47%) patients suffered bleeding complications, while 37 (3.94%) of them had the Bleeding Academic Research Consortium (BARC, type ≥2) bleeding events. We stratified the PRECISE-DAPT score in tertiles (T1: ≤23; T2:24 to 32; T3: ≥33) and found that BARC ≥ 2 type bleeding occurred more frequently in T3 than in T1 and T2 (8.25 vs. 1.46% vs. 2.40%, p <0.05). The ROC curve analysis revealed that the PRECISE-DAPT score cutoff for BARC ≥2 type bleeding prediction was 33. In comparison with the current recommended cutoff score of 25 (AUC: 0.608, based on ROC analysis), the Delong test indicated significantly improved ability for predicting BARC ≥ 2 type bleeding events using the proposed cutoff value of 33, AUC of 0.676 (p = 0.03), and Brier Score of 0.04. The multivariable logistic regression analysis demonstrated that the PRECISE-DAPT score ≥ 33 [OR: 3.772; 95% CI (1.229, 11.578); p = 0.02] was associated with BARC ≥ 2 type bleeding event, along with a history of hemorrhagic stroke [OR: 6.806; 95% CI (1.465, 31.613); p = 0.014], peptic ulcer [OR: 3.871; 95% CI (1.378, 10.871); p = 0.01], and/or myocardial infarction [MI, OR: 3.081; 95% CI (1.140, 8.326); p = 0.027].Conclusion: A higher PRECISE-DAPT score of 33 might be a more reasonable cutoff value for predicting BARC ≥2 type bleeding risk in CAD patients (≥75 years). In addition, the history of hemorrhagic stroke, peptic ulcer, and myocardial infarction were identified as the risk factors of BARC ≥2 type bleeding events.https://www.frontiersin.org/articles/10.3389/fphar.2021.661619/fullbleeding riskdual antiplatelet therapyelderly patientsPRECISE-DAPT scorerisk factors
collection DOAJ
language English
format Article
sources DOAJ
author Yanxia Qian
Bing Xu
Xiaodong Qian
Lu Cao
Yujia Cheng
Xinjian Liu
Xinjian Liu
Song Bai
Zhijun Han
Junhong Wang
Junhong Wang
spellingShingle Yanxia Qian
Bing Xu
Xiaodong Qian
Lu Cao
Yujia Cheng
Xinjian Liu
Xinjian Liu
Song Bai
Zhijun Han
Junhong Wang
Junhong Wang
Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation
Frontiers in Pharmacology
bleeding risk
dual antiplatelet therapy
elderly patients
PRECISE-DAPT score
risk factors
author_facet Yanxia Qian
Bing Xu
Xiaodong Qian
Lu Cao
Yujia Cheng
Xinjian Liu
Xinjian Liu
Song Bai
Zhijun Han
Junhong Wang
Junhong Wang
author_sort Yanxia Qian
title Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation
title_short Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation
title_full Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation
title_fullStr Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation
title_full_unstemmed Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation
title_sort incidence and risk factors for antiplatelet therapy–related bleeding complications among elderly patients after coronary stenting: a multicenter retrospective observation
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2021-07-01
description Purpose: To determine the incidence and risk factors of bleeding events as well as assess the performance of the PRECISE-DAPT score in elderly patients (≥75 years) who underwent percutaneous coronary intervention (PCI) and one-year dual antiplatelet therapy (DAPT).Methods: A total of 940 patients (≥75 years) who received PCI and one-year DAPT were retrospectively enrolled into the study. The multivariable logistic regression analysis was conducted to identify risk factors of antiplatelet-related bleeding complications. The receiver operating characteristic (ROC) curve analysis and the Delong test were performed to obtain the optimized PRECISE-DAPT score.Results: It was observed that 89 (9.47%) patients suffered bleeding complications, while 37 (3.94%) of them had the Bleeding Academic Research Consortium (BARC, type ≥2) bleeding events. We stratified the PRECISE-DAPT score in tertiles (T1: ≤23; T2:24 to 32; T3: ≥33) and found that BARC ≥ 2 type bleeding occurred more frequently in T3 than in T1 and T2 (8.25 vs. 1.46% vs. 2.40%, p <0.05). The ROC curve analysis revealed that the PRECISE-DAPT score cutoff for BARC ≥2 type bleeding prediction was 33. In comparison with the current recommended cutoff score of 25 (AUC: 0.608, based on ROC analysis), the Delong test indicated significantly improved ability for predicting BARC ≥ 2 type bleeding events using the proposed cutoff value of 33, AUC of 0.676 (p = 0.03), and Brier Score of 0.04. The multivariable logistic regression analysis demonstrated that the PRECISE-DAPT score ≥ 33 [OR: 3.772; 95% CI (1.229, 11.578); p = 0.02] was associated with BARC ≥ 2 type bleeding event, along with a history of hemorrhagic stroke [OR: 6.806; 95% CI (1.465, 31.613); p = 0.014], peptic ulcer [OR: 3.871; 95% CI (1.378, 10.871); p = 0.01], and/or myocardial infarction [MI, OR: 3.081; 95% CI (1.140, 8.326); p = 0.027].Conclusion: A higher PRECISE-DAPT score of 33 might be a more reasonable cutoff value for predicting BARC ≥2 type bleeding risk in CAD patients (≥75 years). In addition, the history of hemorrhagic stroke, peptic ulcer, and myocardial infarction were identified as the risk factors of BARC ≥2 type bleeding events.
topic bleeding risk
dual antiplatelet therapy
elderly patients
PRECISE-DAPT score
risk factors
url https://www.frontiersin.org/articles/10.3389/fphar.2021.661619/full
work_keys_str_mv AT yanxiaqian incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
AT bingxu incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
AT xiaodongqian incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
AT lucao incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
AT yujiacheng incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
AT xinjianliu incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
AT xinjianliu incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
AT songbai incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
AT zhijunhan incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
AT junhongwang incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
AT junhongwang incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation
_version_ 1721247627019812864